Joan Bargay Lleonart-rekin lankidetzan egindako argitalpenak (5)

2015

  1. Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: Results from the Spanish registry

    Leukemia, Vol. 29, Núm. 9, pp. 1875-1881

  2. Multivariable time-dependent analysis of the impact of azacitidine in patients with lower-risk myelodysplastic syndrome and unfavorable specific lower-risk score

    Leukemia Research, Vol. 39, Núm. 1, pp. 52-57

2014

  1. Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic Syndromes

    Leukemia and Lymphoma, Vol. 55, Núm. 6, pp. 1300-1303

2013

  1. Survival of hematological patients after discharge from the intensive care unit: A prospective observational study

    Critical Care, Vol. 17, Núm. 6

2009

  1. P136 Allogenic stem cell transplant in MDS: results of the Spanish registry

    Leukemia Research, Vol. 33, Núm. SUPPL. 1